This PR is significant due to the fact that B is showing consistent and robust anti-SARS-CoV-2 activity including on post infected cells. That was the one thing I was hoping would be addressed by the testing after the lung cell results were PRd. Up until today, the results were all pre-infection I believe, but this information suggests that B is as potent ("consistent and robust" after infection as before. Wow!